Herpesvirus: an underestimated virus
Language English Country United States Media print-electronic
Document type Journal Article, Review
PubMed
27858281
DOI
10.1007/s12223-016-0482-7
PII: 10.1007/s12223-016-0482-7
Knihovny.cz E-resources
- MeSH
- Antiviral Agents therapeutic use MeSH
- Herpes Genitalis diagnosis drug therapy epidemiology immunology MeSH
- Herpes Simplex diagnosis drug therapy epidemiology immunology MeSH
- Immunocompromised Host MeSH
- Humans MeSH
- Herpesvirus 1, Human classification drug effects growth & development pathogenicity MeSH
- Herpesvirus 2, Human classification drug effects growth & development pathogenicity MeSH
- Infant, Newborn MeSH
- Virus Replication drug effects genetics MeSH
- Check Tag
- Humans MeSH
- Infant, Newborn MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Antiviral Agents MeSH
Herpes simplex virus (HSV) infections are common and widespread; nevertheless, their outcome can be of unpredictable prognosis in neonates and in immunosuppressed patients. Anti-HSV therapy is effective, but the emergence of drug-resistant strains or the drug toxicity that hamper the treatment is of great concern. Vaccine has not yet shown relevant benefit; therefore, palliative prophylactic measures have been adopted to prevent diseases. This short review proposes to present concisely the history of HSV, its taxonomy, physical structure, and replication and to explore the pathogenesis of the infection, clinical manifestations, laboratory diagnosis, treatment, prophylaxis and epidemiology of the diseases.
See more in PubMed
Antiviral Res. 2012 Jul;95(1):37-48 PubMed
Adv Exp Med Biol. 2012;726:423-39 PubMed
Theor Biol Med Model. 2014 Jun 06;11:27 PubMed
J Virol. 2013 Jul;87(14):8029-37 PubMed
Biochemistry (Mosc). 2014 Dec;79(13):1635-52 PubMed
Curr Pharm Biotechnol. 2015;16(8):724-32 PubMed
Antimicrob Agents Chemother. 2015 Jul;59(7):3718-25 PubMed
Clin Dev Immunol. 2012;2012:187585 PubMed
Annu Rev Microbiol. 2013;67:355-74 PubMed
PLoS Pathog. 2011 Sep;7(9):e1002277 PubMed
J Mol Diagn. 2008 Jul;10(4):361-7 PubMed
Virol J. 2014 May 12;11:83 PubMed
Nat Rev Microbiol. 2008 Mar;6(3):211-21 PubMed
Viruses. 2009 Dec 1;1(3):594-629 PubMed
Antimicrob Agents Chemother. 2013 Jun;57(6):2541-9 PubMed
Schizophr Bull. 2012 Nov;38(6):1137-48 PubMed
Antiviral Res. 2014 Nov;111:36-41 PubMed
J Oral Pathol Med. 2008 Feb;37(2):107-21 PubMed
Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?